Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Cabot Corporation (CBT)

NYSE: CBT · Miscellaneous Chemical Products · Boston, MA

Our rating: Positive

Call changed from Neutral to Positive at $75.10, moderate conviction, November 4, 2026.

Breaks if: The Positive call breaks on the downside if free cash flow for the next full fiscal year comes in below $300M — compressing the FCF yield to roughly 7.7% at today's price — or if the year-over-year revenue decline deepens beyond 12% in the next annual filing; either would signal that volume pressure is structural and that the low multiple is a value trap rather than a cushion. On the upside, we would revisit to Neutral if the stock trades above $97 within the next twelve months without a demonstrated stabilization in revenue growth, at which point the FCF yield would have compressed to roughly 8% and the valuation anchor that underpins this call would largely have closed.

Key figures

Market value$3.6B
Revenue, last 12 months$3.7B
Net income, last 12 months$213M
Free cash flow, last 12 months$214M
Price to earnings17.0×
Free cash flow yield5.9%
Dividend yield2.6%
Operating margin12.7%
Return on equity13.4%
Beta to the S&P 5000.80
Volatility, annualized33.0%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.0B12.2%$1.25$88M
June 30, 2026$982M6.4%$0.12$37M
March 31, 2026$904M−3.4%$1.27$32M
December 31, 2025$849M−11.1%$1.37$57M
September 30, 2025$899M−10.2%$0.80$155M
June 30, 2025$923M−9.2%$1.86$188M
March 31, 2025$936M−8.1%$1.69$1M
December 31, 2024$955M−0.3%$1.67$47M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

9 ledger entries and 24 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.